Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001720081-17-000007
Filing Date
2017-10-23
Accepted
2017-10-23 08:29:16
Documents
1
Period of Report
2017-10-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_150876174291404.html 4  
1 FORM 4 wf-form4_150876174291404.xml 4 3880
  Complete submission text file 0001720081-17-000007.txt   5217
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Issuer) CIK: 0001640455 (see all company filings)

EIN.: 454870634 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O JOUNCE THERAPEUTICS, INC. 780 MEMORIAL DRIVE CAMBRIDGE MA 02138
Business Address
Diaz Luis (Reporting) CIK: 0001720081 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37998 | Film No.: 171148299